Kevin Winthrop, MD, MPH

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Insmed
    Topic:
    NTM
    Date added:
    Date updated:
    04/29/2024
  • Attribution:
    Self
    Type of financial relationship:
    Research Funding (if you were the principal or named investigator)
    Ineligible company:
    Insmed
    Topic:
    NTM research
    Date added:
    Date updated:
    04/29/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    RedHill Biopharma
    Topic:
    NTM
    Date added:
    Date updated:
    04/29/2024
  • Attribution:
    Self
    Type of financial relationship:
    Research Funding (if you were the principal or named investigator)
    Ineligible company:
    RedHill Biopharma
    Topic:
    NTM research
    Date added:
    Date updated:
    04/29/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Spero
    Topic:
    NTM
    Date added:
    Date updated:
    04/29/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    AN2 Therapeutics
    Topic:
    NTM
    Date added:
    02/07/2022
    Date updated:
    04/29/2024
  • Attribution:
    Self
    Type of financial relationship:
    Research Funding (if you were the principal or named investigator)
    Ineligible company:
    AN2 Therapeutics
    Topic:
    NTM research
    Date added:
    02/07/2022
    Date updated:
    04/29/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Paratek
    Topic:
    NTM
    Date added:
    02/07/2022
    Date updated:
    04/29/2024
  • Attribution:
    Self
    Type of financial relationship:
    Research Funding (if you were the principal or named investigator)
    Ineligible company:
    Paratek
    Topic:
    NTM research
    Date added:
    02/07/2022
    Date updated:
    04/29/2024
Return to 2022 Infectious Disease Board Review Course